Omega-3

Algae producer Cellana nears full scale production phase

Algae producer Cellana nears full scale production phase

By Hank Schultz

Another company developing algal ingredients is set to make a splash in the market.  San Diego-based Cellana has finished its development phase and is close to entering full scale production, according to company officials.

Neptune's strong sales helped cushion blow of plant explosion

Neptune's strong sales helped cushion blow of plant explosion

By Hank Schultz

Neptune Technologies and Bioressources has released its year end results for fiscal year 2013 which show that strong sales earlier in the year helped cushion the blow dealt to the company’s finances by the explosion and fire that devastated the company’s...

USPTO rejects one of Neptune's krill patents; appeal forthcoming

USPTO rejects one of Neptune's krill patents; appeal forthcoming

By Hank Schultz

In the latest development in the nutraceutical world’s equivalent of the Wars of the Roses, the United States Patent and Trademark Office has ruled on a reexamination of a Neptune Bioressources and Technologies patent and has rejected all of its 148 claims.

New process converts omega-3 oils into powders

New process converts omega-3 oils into powders

By Jane Joseph

Dynamic Extractions and Formulations (DEF) claims a new process that converts omega-3 and other oils into stabilised fine powders improves the nutritional value and shelf life of the product.

DSM teams up with Oceans Omega for emulsions

DSM teams up with Oceans Omega for emulsions

By Stephen DANIELLS

Ingredients giant DSM Nutritional Products has enhanced it omega-3 portfolio with a supply agreement with Oceans Omega LLC and its OTEC emulsion ingredients.

Should vegetarians take supplements of EPA and DHA omega-3s?

Dispatches from the 6th International Congress on Vegetarian Nutrition

Should vegans and vegetarians take supplements of EPA and DHA omega-3s?

By Elaine WATSON

If they don’t eat fish, vegans and vegetarians get very little EPA and DHA, the long chain omega-3 fatty acids we are told are key for maintaining cardiovascular and cognitive health. But is this a problem that needs to be fixed? And are algal omega-3...

GOED: Pharma is important for omega-3 but growing slowly

GOED: Pharma is important for omega-3 but growing slowly

By Shane Starling

Pharmaceutical omega-3 products are important but will grow more slowly than some expect because of the long timeframe for drug approval, says the chief of the Global Organisation for EPA and DHA Omega-3s (GOED).

How high can high-end omega-3 go?

Special edition: Omega-3 (Editor's blog)

How high can high-end omega-3 go?

By Shane STARLING

Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted BASF and DSM to the sector. His word: “Stellar”.

Marine omega-3 sources are clearing sustainability bar - so far

Special edition: Omega-3s

Marine omega-3 sources are clearing sustainability bar - so far

By Hank Schultz

Fish oil, an ingredient with a 150-year plus history as a nutraceutical, continues to be the mainstay of the world’s supply of omega-3s.  But, with all of the questions hovering over the health of the oceans, how much longer can suppliers and manufacturers...

Finding the sweet spot in the algal omega-3 market

Special edition: Omega-3

Finding the sweet spot in the algal omega-3 market

By Elaine WATSON

Most experts say we have barely scratched the surface when it comes to exploring the commercial potential of microalgae. But who is best-placed to translate this promise into hard cash in the food and dietary supplement market?

Neptune and Aker facing off in court yet again

Krill wars

Neptune and Aker facing off in court yet again

By RJ Whitehead

Australia is the site of the latest battle between Neptune and Aker Biomarine. In addition to patent strife between the two krill majors in American courts, Canadian Neptune has now announced that it filed opposition to an Aker patent application earlier...

Reckitt Benckiser bids $1.4bn for Schiff

Reckitt Benckiser-Schiff: Another giant jumps into nutra space

By Shane STARLING

UK-based consumer goods firm Reckitt Benckiser told NutraIngredients today, “nutrition had been on its radar for awhile”, as it plunged $1.4bn (€1.09bn) to outbid German pharma firm Bayer for the US’s second biggest dietary supplements firm, Schiff Nutrition...

Follow us

Products

View more

Webinars